Cargando…

Lessons from the Cerebrospinal Fluid Analysis of HTLV-1-Infected Individuals: Biomarkers of Inflammation for HAM/TSP Development

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a neurodegenerative disease that leads to motor impairment due to a chronic inflammatory process in the central nervous system (CNS). However, the HAM/TSP pathogenesis is not completely clear, and biomarkers to define the disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freitas, Nicole Lardini, Gomes, Yago Côrtes Pinheiro, Souza, Flávia dos Santos, Torres, Rafael Carvalho, Echevarria-Lima, Juliana, Leite, Ana Claudia Celestino Bezerra, Lima, Marco Antonio Sales Dantas, Araújo, Abelardo Queiroz Campos, Silva, Marcus Tulius Teixeira, Espíndola, Otávio de Melo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609689/ https://www.ncbi.nlm.nih.gov/pubmed/36298702 http://dx.doi.org/10.3390/v14102146

Ejemplares similares

Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression
por: Gomes, Yago Côrtes Pinheiro, et al.
Publicado: (2022)

Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression
por: Souza, Flávia dos Santos, et al.
Publicado: (2021)

Protein Profile of Blood Monocytes is Altered in HTLV-1 Infected Patients: Implications for HAM/TSP Disease
por: Echevarria-Lima, Juliana, et al.
Publicado: (2018)

Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development
por: Espíndola, Otávio Melo, et al.
Publicado: (2021)

Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid
por: Espíndola, Otávio de Melo, et al.
Publicado: (2020)

HAM/TSP in relatives of HAM/TSP cases and in relatives of asymptomatic HTLV-1 carriers
por: Alvarez, Carolina, et al.
Publicado: (2014)

HTLV-1 proviral load of HAM/TSP patients according to new diagnostic criteria of HAM/TSP
por: Grassi, Maria F R, et al.
Publicado: (2011)

HTLV-1 proviral load as an indicative marker of HAM/TSP: a systematic review of studies of patients with HAM/TSP
por: Bassi, Shiva Shaan, et al.
Publicado: (2014)

Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2017)

Association Between HTLV-1 Genotypes and Risk of HAM/TSP
por: Saito, Mineki
Publicado: (2019)

Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid and Accurate Confirmatory Diagnosis of HTLV-1/2 Infection
por: Gomes, Yago, et al.
Publicado: (2020)

Comparison of Static Balance Control in Infected Htlv-1 Subjects with Different Tsp/Ham Diagnosis
por: Costa, Kelly Helorany Alves, et al.
Publicado: (2022)

Vestibulospinal tract dysfunction in HTLV-1-asymptomatic infection and in HAM/TSP
por: Labanca, Ludimila, et al.
Publicado: (2014)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients
por: Vakili, Rosita, et al.
Publicado: (2013)

HAM/TSP introduction: systematic review of HAM/TSP clinical trials
por: Anderson, Rebecca, et al.
Publicado: (2014)

An interferon signature is associated with HAM/TSP but not viral containment in HTLV-1 infection
por: Tattermusch, Sonja, et al.
Publicado: (2011)

HAM/TSP Pathogenesis: The Transmigration Activity of HTLV-1-Infected T Cells into Tissues
por: Nakamura, Tatsufumi
Publicado: (2023)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Rafatpanah, Houshang, et al.
Publicado: (2013)

High HTLV-I proviral load in patients with HAM/TSP and ATLL but not with other disorders
por: Altamirano, Natalia, et al.
Publicado: (2011)

Proteomic profiles among asymptomatic HTLV-1 carriers and HAM/TSP patients in Peru
por: Temoche, Morayma, et al.
Publicado: (2014)

Molecular and clinical analyses of HTLV-1 subgroups associated with the risk of developing HAM/TSP.
por: Saito, Mineki, et al.
Publicado: (2015)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2019)

HAM/TSP and major depression: the role of age
por: Boa-Sorte, Ney, et al.
Publicado: (2015)

Inflammation with HTLV-1-specific CTLs occurs in the spinal cord of HTLV-1 carriers and the brain of the patients with HAM/TSP
por: Matsuura, Eiji, et al.
Publicado: (2014)

Managing HAM/TSP with Fampridine
por: Menna-Barreto, M Marcio
Publicado: (2014)

Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients
por: Queiroz, Gabriel Andrade Nonato, et al.
Publicado: (2019)

HTLV-1 Integration into Transcriptionally Active Genomic Regions Is Associated with Proviral Expression and with HAM/TSP
por: Meekings, Kiran N., et al.
Publicado: (2008)

Neurological manifestations in HTLV-1 patients with overactive bladder syndrome. A precursor of HAM/TSP?
por: Costa, Davi, et al.
Publicado: (2011)

Integration site analysis in Japanese HTLV-1 infected asymptomatic carriers and HAM/TSP patients
por: Niederer, Heather, et al.
Publicado: (2014)

HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP
por: Niederer, Heather A, et al.
Publicado: (2014)

Nutritional status and behavioral factors of individuals with HTLV-1 and tropical spastic paraparesis (HAM / TSP)
por: Carvalho, Catia L, et al.
Publicado: (2015)

Characteristics of HAM/TSP after kidney transplantation from HTLV-1 positive living donors
por: Kimura, Miyuna, et al.
Publicado: (2015)

Cyclosporine for the Treatment of HTLV-1-Induced HAM/TSP: An Experience from a Case Report
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2015)

Hypovitaminosis D Is Associated with Higher Levels of Inflammatory Cytokines and with HAM/TSP in HTLV-Infected Patients
por: Netto, Elaine Coutinho, et al.
Publicado: (2021)

A NKG2D Thr72Ala polymorphism is not associated with HAM/TSP and proviral load values in Peruvian HTLV-1 infected patients with HAM/TSP and asymptomatic carriers
por: Bernia, Cynthia, et al.
Publicado: (2015)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

Putative role of HLA polymorphism among a Brazilian HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) population
por: Schor, Doris, et al.
Publicado: (2023)

Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP
por: Santana, Bárbara Brasil, et al.
Publicado: (2021)

CD64 as a biomarker and therapeutic target in HAM/TSP and HTLV-1-associated Infective Dermatitis
por: Khouri, Ricardo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ob9r74dvo4rhem0n59tm3kl1en